Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 5
Submit an article Journal homepage
184
Views
39
CrossRef citations to date
0
Altmetric
Original Articles: Research

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

Jessica A. ShaferCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USACorrespondence[email protected]
,
Conrad R. CruzCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
Ann M. LeenCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
Stephanie KuCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
An LuCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
Alexandra RousseauCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
Helen E. HeslopCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
Cliona M. RooneyCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
,
Catherine M. BollardCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
&
Aaron E. FosterCenter for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, The Methodist Hospital and Texas Children's Cancer Center, Houston, TX, USA
 show all
Pages 870-880 | Received 23 Nov 2009, Accepted 18 Feb 2010, Published online: 06 Apr 2010

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Benjamin Rengstl, Frederike Schmid, Christian Weiser, Claudia Döring, Tim Heinrich, Kathrin Warner, Petra S. A. Becker, Robin Wistinghausen, Sima Kameh-Var, Eva Werling, Arne Billmeier, Christian Seidl, Sylvia Hartmann, Hinrich Abken, Ralf Küppers, Martin-Leo Hansmann & Sebastian Newrzela. (2016) Tumor-infiltrating HLA-matched CD4+ T cells retargeted against Hodgkin and Reed–Sternberg cells. OncoImmunology 5:6.
Read now
Ralf Küppers. (2010) Side population cells in Hodgkin lymphoma. Leukemia & Lymphoma 51:5, pages 741-742.
Read now

Articles from other publishers (37)

Amy B. Hont, Allison B. Powell, Danielle K. Sohai, Izabella K. Valdez, Maja Stanojevic, Ashley E. Geiger, Kajal Chaudhary, Ehsan Dowlati, Catherine M. Bollard & Conrad Russell Y. Cruz. (2022) The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease. Molecular Therapy 30:6, pages 2130-2152.
Crossref
Helen Ma, Craig R. Soderquist, Enrica Marchi, Luigi Scotto, Govind Bhagat & Owen A. O'Connor. (2020) Cancer testis antigen expression across T‐cell lymphoma subtypes. Hematological Oncology 38:5, pages 827-830.
Crossref
Ayad M. Al-Katib, Abdul Shukkur Ebrahim, Mustapha Kandouz, Feras Zaiem, Ali Raufi, Salah Ebrahim, Anwar Mohamed, Nada Emara & Ali M. Gabali. (2020) Isolation and characterization of a CD34+ sub-clone in B-cell lymphoma. Oncotarget 11:2, pages 148-160.
Crossref
Andreas Rosenwald & Ralf Küppers. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma 47 68 .
Lina Gu, Meixiang Sang, Juan Li, Fei Liu, Yunyan Wu, Shina Liu & Baoen Shan. (2019) Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma. Digestive and Liver Disease 51:10, pages 1475-1482.
Crossref
Jean-Philippe Bastien, Annabelle Minguy, Vibhuti Dave & Denis Claude Roy. (2019) Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment. Seminars in Immunology 42, pages 101306.
Crossref
Melanie L. Grant & Catherine M. Bollard. (2018) Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!. Blood Reviews 32:3, pages 203-224.
Crossref
Ralf Küppers. 2018. Hematology. Hematology 1204 1211 .
Ralf Küppers. 2018. Precision Molecular Pathology of Hodgkin Lymphoma. Precision Molecular Pathology of Hodgkin Lymphoma 35 57 .
Melanie Grant & Catherine M. Bollard. (2017) Developing T-cell therapies for lymphoma without receptor engineering. Blood Advances 1:26, pages 2579-2590.
Crossref
Melanie Grant & Catherine M. Bollard. (2017) Developing T-cell therapies for lymphoma without receptor engineering. Hematology 2017:1, pages 622-631.
Crossref
Kunio Iura, Kenichi Kohashi, Takeaki Ishii, Akira Maekawa, Hirofumi Bekki, Hiroshi Otsuka, Yuichi Yamada, Hidetaka Yamamoto, Yoshihiro Matsumoto, Yukihide Iwamoto & Yoshinao Oda. (2017) MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1. Virchows Archiv 471:3, pages 383-392.
Crossref
Jiandong Zhang, Meixiang Sang, Lina Gu, Fei Liu, Weijing Li, Danjing Yin, Yunyan Wu, Shina Liu, Weina Huang & Baoen Shan. (2017) Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide. Journal of Immunotherapy 40:6, pages 211-220.
Crossref
Benjamin Rengstl, Sooji Kim, Claudia Döring, Christian Weiser, Julia Bein, Katrin Bankov, Marco Herling, Sebastian Newrzela, Martin-Leo Hansmann & Sylvia Hartmann. (2017) Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other. PLOS ONE 12:5, pages e0177378.
Crossref
Tatjana Maria Swerev, Thomas Wirth & Alexey Ushmorov. (2017) Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: A rationale for combination with small molecular weight inhibitors. International Journal of Oncology 50:2, pages 555-566.
Crossref
Stephan Mathas, Sylvia Hartmann & Ralf K?ppers. (2016) Hodgkin lymphoma: Pathology and biology. Seminars in Hematology 53:3, pages 139-147.
Crossref
Catherine M Bollard, C Russell Cruz & A John Barrett. (2015) Directed T-cell therapies for leukemia and lymphoma after hematopoietic stem cell transplant: beyond chimeric antigen receptors. International Journal of Hematologic Oncology 4:3, pages 99-111.
Crossref
Andreas Rosenwald & Ralf Küppers. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 45 64 .
Catherine M. Bollard & A. John Barrett. (2014) Cytotoxic T lymphocytes for leukemia and lymphoma. Hematology 2014:1, pages 565-569.
Crossref
Martin Hildebrandt, Karl Peggs, Lutz Uharek, Catherine M. Bollard & Helen E. Heslop. (2014) Immunotherapy: opportunities, risks and future perspectives. Cytotherapy 16:4, pages S120-S129.
Crossref
Mark PodberezinJianguo WenChung-Che (Jeff Chang. (2013) Cancer Stem Cells: A Review of Potential Clinical Applications. Archives of Pathology & Laboratory Medicine 137:8, pages 1111-1116.
Crossref
Ralf Küppers, Andreas Engert & Martin-Leo Hansmann. (2012) Hodgkin lymphoma. Journal of Clinical Investigation 122:10, pages 3439-3447.
Crossref
Hyoung Jin Kang, Cliona M. Rooney & Helen E. Heslop. 2013. Childhood Leukemias. Childhood Leukemias 582 592 .
Stefanie Kewitz, Toralf Bernig & Martin S. Staege. (2012) Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells. Leukemia Research 36:6, pages 773-778.
Crossref
Mark Roschewski & Wyndham H. Wilson. (2012) EBV-associated lymphomas in adults. Best Practice & Research Clinical Haematology 25:1, pages 75-89.
Crossref
Luis de la Cruz-Merino, Marylène Lejeune, Esteban Nogales Fernández, Fernando Henao Carrasco, Ana Grueso López, Ana Illescas Vacas, Mariano Provencio Pulla, Cristina Callau & Tomás Álvaro. (2012) Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications. Clinical and Developmental Immunology 2012, pages 1-24.
Crossref
Ulrike Gerdemann, Usha Katari, Anne S Christin, Conrad R Cruz, Tamara Tripic, Alexandra Rousseau, Stephen M Gottschalk, Barbara Savoldo, Juan F Vera, Helen E Heslop, Malcolm K Brenner, Catherine M Bollard, Cliona M Rooney & Ann M Leen. (2011) Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma. Molecular Therapy 19:12, pages 2258-2268.
Crossref
Katayoun Rezvani. (2011) MAGE: The Spell Is Broken. Clinical Cancer Research 17:22, pages 6955-6957.
Crossref
Conrad R. Cruz, Ulrike Gerdemann, Ann M. Leen, Jessica A. Shafer, Stephanie Ku, Benjamin Tzou, Terzah M. Horton, Andrea Sheehan, Amanda Copeland, Anas Younes, Cliona M. Rooney, Helen E. Heslop & Catherine M. Bollard. (2011) Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4. Clinical Cancer Research 17:22, pages 7058-7066.
Crossref
J Bae, R Carrasco, A-H Lee, R Prabhala, Y-T Tai, K C Anderson & N C Munshi. (2011) Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma. Leukemia 25:10, pages 1610-1619.
Crossref
Ingrid Glimelius, Jenny Rubin, Marie Fischer, Daniel Molin, Rose-Marie Amini, Per Venge & Gunilla Enblad. (2011) Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines. Experimental Hematology 39:8, pages 850-858.
Crossref
Seok Jin Kim. (2011) Lymphoma stem cells: A step toward a new therapeutic target. The Korean Journal of Hematology 46:4, pages 211.
Crossref
Claudio Fozza & Maurizio Longinotti. (2011) T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications. Advances in Hematology 2011, pages 1-8.
Crossref
Diponkar Banerjee. (2011) Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies. Advances in Hematology 2011, pages 1-19.
Crossref
Mikhail Roshal, Brent L. Wood & Jonathan R. Fromm. (2011) Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications. Advances in Hematology 2011, pages 1-9.
Crossref
Katrina Farrell & Ruth F Jarrett. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology 58:1, pages 15-25.
Crossref
Mads Hald Andersen, Niels Junker, Eva Ellebaek, Inge Marie Svane & Per thor Straten. (2010) Therapeutic Cancer Vaccines in Combination with Conventional Therapy. Journal of Biomedicine and Biotechnology 2010, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.